Market at a critical inflation point that could confirm or deny the strength that is average for stocks in the month of April.
*** Stocks highlighted are for information purposes only and should not be considered as advice to purchase or to sell mentioned securities. As always, the use of technical and fundamental analysis is encouraged in order to fine tune entry and exit points to average seasonal trends.
Stocks Entering Period of Seasonal Strength Today:
Subscribers Click on the relevant link to view the full profile. Not a subscriber? Signup here.
Stock Highlight:
|
|
- Optimal holding period from April 2nd to July 20th
- The ETF ran higher through the back half of last year, leading to a multi-month consolidation phase that now appears to be resolving. Initial upside target is back to the 2021 high around $61, or approximately 15% above present levels.
- The fund provides exposure to small- and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the US Food and Drug Administration clinical trials.
|
Disclaimer: Comments and opinions offered in this report are for information only. They should not be considered as advice to purchase or to sell mentioned securities. Data offered is believed to be accurate, but is not guaranteed.
Super Simple Seasonal Portfolio
This content is exclusive to subscribers of EquityClock.com. Please Log In or Subscribe to proceed.
